Yaobo Xu

Yaobo Xu

Auto-generated profile, based on publicly available information

Yaobo Xu

Wellcome Sanger Institute, Cambridge, UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2015 in Blood
Verified
Journal Article
Open access
PDF file
JMJoshua D. Milner
Joshua D. Milner
TVTiphanie P. Vogel
Tiphanie P. Vogel
LFLisa Forbes
Lisa Forbes
CMChi A. Ma
Chi A. Ma
ASAsbjørg Stray-Pedersen
Asbjørg Stray-Pedersen
MCMegan A. Cooper
Megan A. Cooper
Key Points: Germline gain-of-function mutations in STAT3 lead to lymphoproliferation and autoimmunity with prominent cytopenias. Mutations in STAT3 cause altered regulatory T cells and cytokine signaling.

12 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAdriana G. B. Buskin
Adriana G. B. Buskin
LZLili Zhu
Lili Zhu
VCValeria Chichagova
Valeria Chichagova
BBBasudha Basu
Basudha Basu
SMSina Mozaffari-Jovin
Sina Mozaffari-Jovin
MLMajlinda Lako
Majlinda Lako
Mutations in pre-mRNA processing factors (PRPFs) cause autosomal-dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed genes cause non-syndromic retinal disease. Here, we generate transcriptome profiles from RP11 (PRPF31-mutated) patient-derived retinal organoids and retinal pigment epithelium (RPE), as well as Prpf31+/− mouse tissues, which revealed that disrupted alternative splicing occurred for specific splicing programmes. Mis-splicing of genes encoding pre-mRNA splicing proteins was limited to patient-specific retinal cells and Prpf31+/− mouse retinae and RPE. Mis-splicing of genes implicated in ciliogenesis and cellular adhesion was associated with severe RPE defects that include disrupted apical – basal polarity, reduced trans-epithelial resistance and phagocytic capacity, and decreased cilia length and incidence. Disrupted cilia morphology also occurred in patient-derived photoreceptors, associated with progressive degeneration and cellular stress. In situ gene editing of a pathogenic mutation rescued protein expression and key cellular phenotypes in RPE and photoreceptors, providing proof of concept for future therapeutic strategies.

1 September 2012 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
YXY. Xu
Y. Xu
MBM.J. Barter
M.J. Barter
DSDaniel Swan
Daniel Swan
KRKenneth Rankin
Kenneth Rankin
ARA.D. Rowan
A.D. Rowan
DYDavid Young
David Young

26 October 2016 in Frontiers in Neuroanatomy
Verified
Journal Article
Open access
PDF file
SLSusan J. Lindsay
Susan J. Lindsay
YXYaobo Xu
Yaobo Xu
SLSteven N. Lisgo
Steven N. Lisgo
LHLauren F. Harkin
Lauren F. Harkin
ACAndrew J. Copp
Andrew J. Copp
PCPatrick F. Chinnery
Patrick F. Chinnery
HDBR Expression: A Unique Resource for Global and Individual Gene Expression Studies during Early Human Brain Development

15 December 2017 in Development
Verified
Journal Article
Open access
PDF file
MBMatt J. Barter
Matt J. Barter
Rodolfo GómezRodolfo Gómez
Rodolfo Gómez
SHSam Hyatt
Sam Hyatt
KCKat Cheung
Kat Cheung
ASAndrew J. Skelton
Andrew J. Skelton
DYDavid Young
David Young
Long non-coding RNAs (lncRNAs) are expressed in a highly tissue-specific manner and function in various aspects of cell biology, often as key regulators of gene expression. In this study, we established a role for lncRNAs in chondrocyte differentiation. Using RNA sequencing we identified a human articular chondrocyte repertoire of lncRNAs from normal hip cartilage donated by neck of femur fracture patients. Of particular interest are lncRNAs upstream of the master chondrocyte transcription factor SOX9 locus. SOX9 is an HMG-box transcription factor that plays an essential role in chondrocyte development by directing the expression of chondrocyte-specific genes. Two of these lncRNAs are upregulated during chondrogenic differentiation of mesenchymal stem cells (MSCs). Depletion of one of these lncRNAs, LOC102723505, which we termed ROCR (regulator of chondrogenesis RNA), by RNA interference disrupted MSC chondrogenesis, concomitant with reduced cartilage-specific gene expression and incomplete matrix component production, indicating an important role in chondrocyte biology. Specifically, SOX9 induction was significantly ablated in the absence of ROCR, and overexpression of SOX9 rescued the differentiation of MSCs into chondrocytes. Our work sheds further light on chondrocyte-specific SOX9 expression and highlights a novel method of chondrocyte gene regulation involving a lncRNA.

9 October 2017 in Stem Cells
Verified
Journal Article
Open access
PDF file
DHDean Hallam
Dean Hallam
JCJoseph Collin
Joseph Collin
SBSanja Bojic
Sanja Bojic
VCValeria Chichagova
Valeria Chichagova
ABAdriana G. B. Buskin
Adriana G. B. Buskin
MLMajlinda Lako
Majlinda Lako
Age-related macular degeneration (AMD) is the most common cause of blindness, accounting for 8.7% of all blindness globally. Vision loss is caused ultimately by apoptosis of the retinal pigment epithelium (RPE) and overlying photoreceptors. Treatments are evolving for the wet form of the disease; however, these do not exist for the dry form. Complement factor H polymorphism in exon 9 (Y402H) has shown a strong association with susceptibility to AMD resulting in complement activation, recruitment of phagocytes, RPE damage, and visual decline. We have derived and characterized induced pluripotent stem cell (iPSC) lines from two subjects without AMD and low-risk genotype and two patients with advanced AMD and high-risk genotype and generated RPE cells that show local secretion of several proteins involved in the complement pathway including factor H, factor I, and factor H-like protein 1. The iPSC RPE cells derived from high-risk patients mimic several key features of AMD including increased inflammation and cellular stress, accumulation of lipid droplets, impaired autophagy, and deposition of “drüsen”-like deposits. The low- and high-risk RPE cells respond differently to intermittent exposure to UV light, which leads to an improvement in cellular and functional phenotype only in the high-risk AMD-RPE cells. Taken together, our data indicate that the patient specific iPSC model provides a robust platform for understanding the role of complement activation in AMD, evaluating new therapies based on complement modulation and drug testing. Stem Cells 2017;35:2305–2320